24.36 USD
↘ 1.27 (4.96%)AT CLOSE (03:59 PM EDT)
Xencor, Inc.
XNCRNASDAQ • USD
24.36
↘ 0.00 (0.02%)
POST MARKET (AS OF 04:15 PM EDT)
Post Market
AS OF 04:15 PM EDT
24.36
↘ 0.00 (0.02%)
Market: OPEN
Shares of Xencor, Inc. (XNCR) are trading at $24.36. Our models show a "Buy" technical signal alongside a "Neutral" fundamental rating. Notable factors include a robust Altman Z-Score, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Oct 5, 2026.
Open?$25.76
High?$26.03
Low?$23.89
Prev. Close?$25.63
Volume?1.2M
Avg. Volume?1.5M
VWAP?$24.54
Rel. Volume?0.85x
Bid / Ask
Bid?$20.75 × 100
Ask?$30.51 × 100
Spread?$9.76
Midpoint?$25.63
Valuation & Ratios
Market Cap?1.9B
Shares Out?74.4M
Float?72.3M
Float %?97.2%
P/E Ratio?N/A
P/B Ratio?3.79
EPS?-$2.20
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
Themes
Address
465 N. HALSTEAD ST.
PASADENA, CA 91107
Phone: 626-305-5900
PASADENA, CA 91107
Phone: 626-305-5900
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?77
Momentum?57
Short Sent.?34
Piotroski F-Score?4/9Mixed
Altman Z-Score?3.22Safe
Confidence?65%Moderate
Short InterestSqueeze Risk
Short % of Float?21.80%Squeeze Risk
Short Interest?15.8M
Days to Cover?13.2
Free Float72.3M
Avg Daily Volume1.2M
Settlement Date2026-09-15
Financial Health
Current Ratio?6.39Strong
Quick Ratio?6.39Strong
Cash Ratio?0.55Adequate
Debt/Equity?0.21Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?3.79FAIR▾
Peers100
S&P46
P/S?18.15HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-9.6CHEAP▾
S&P97
EV/Sales?18.73HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-32.5%WEAK▾
S&P6
ROA?-22.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-208285000
Enterprise Value?$2.0B
Fundamentals ratios updated end of day